Literature DB >> 10613579

In-the-bag secondary intraocular lens implantation in children.

M E Wilson1, J A Englert, M J Greenwald.   

Abstract

BACKGROUND: Surgery for congenital cataracts in early infancy usually includes a primary posterior capsulectomy and an anterior vitrectomy. Initially, most of these infants have aphakia after surgery. Over time, remaining equatorial lens epithelial cells produce new cortical fibers, resulting in a ring of cortex trapped between the lens equator and the fused anterior and posterior capsulectomy edges. A potential space is maintained between the anterior and posterior capsular leaflets. We describe a technique for placing a secondary intraocular lens (IOL) within the capsular bag. PATIENTS AND METHODS: Eight children, ranging in age from 11 months to 14 years, who originally had aphakia after cataract extraction were operated on with the intent to reopen the capsular bag and place an IOL in the bag.
RESULTS: Secondary in-the-bag IOL implantation was successfully completed in 7 of 8 children. This was accomplished by reopening the capsular bag 360 degrees at the edge of the fused anterior and posterior capsulectomy remnants, using the previously published vitrectorhexis technique. Residual cortical material was aspirated, and an IOL was placed within the capsular bag. In 1 child, aged 14 years, the capsular bag was reopened, but the lens was placed in the ciliary sulcus because the new anterior capsule edge could not be visualized for 360 degrees .
CONCLUSION: Placement of secondary IOLs within the capsular bag can be accomplished successfully for selected patients in the pediatric population. Surgeons operating on infantile cataracts without primary IOL placement can facilitate capsular IOL sequestration later by limiting the anterior and posterior capsulectomy to 4 to 5 mm and performing a generous anterior vitrectomy to help prevent secondary closure of the smaller capsulectomy.

Entities:  

Mesh:

Year:  1999        PMID: 10613579     DOI: 10.1016/s1091-8531(99)70044-3

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  7 in total

1.  Pupil occlusion due to a large dislocated Soemmering ring in an aphakic eye.

Authors:  Ali Akal; Tuğba Göncü; Isa Yuvaci; Emine Pangal; Sevin Cakmak
Journal:  Int Ophthalmol       Date:  2013-03-01       Impact factor: 2.031

2.  Reply: To PMID 23639132.

Authors:  Scott R Lambert; Hillary M Superak; Mike J Lynn; Allen D Beck
Journal:  Am J Ophthalmol       Date:  2013-09       Impact factor: 5.258

3.  Angle Closure Glaucoma Secondary to Enlarged Soemmering Ring That is Clinically Similar to Iris Tumour.

Authors:  Babak Masoomian; Maryam Saatchi; Fariba Ghassemi; Hamid Riazi-Esfahani; Zakieh Vahedian
Journal:  Int Med Case Rep J       Date:  2020-08-05

4.  The infant aphakia treatment study: design and clinical measures at enrollment.

Authors:  Scott R Lambert; Edward G Buckley; Carolyn Drews-Botsch; Lindreth DuBois; Eugenie Hartmann; Michael J Lynn; David A Plager; M Edward Wilson
Journal:  Arch Ophthalmol       Date:  2010-01

5.  Complications in the first 5 years following cataract surgery in infants with and without intraocular lens implantation in the Infant Aphakia Treatment Study.

Authors:  David A Plager; Michael J Lynn; Edward G Buckley; M Edward Wilson; Scott R Lambert
Journal:  Am J Ophthalmol       Date:  2014-07-29       Impact factor: 5.258

6.  In-the-bag intraocular lens placement via secondary capsulorhexis with radiofrequency diathermy in pediatric aphakic eyes.

Authors:  Lixia Luo; Haotian Lin; Weirong Chen; Chunxiao Wang; Xinyu Zhang; Xiangchen Tang; Jianping Liu; Nathan Congdon; Jingjing Chen; Zhuoling Lin; Yizhi Liu
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

7.  Outcomes of secondary intraocular lens implantation in the Infant Aphakia Treatment Study.

Authors:  Deborah K VanderVeen; Carolyn D Drews-Botsch; Azhar Nizam; Erick D Bothun; Lorri B Wilson; M Edward Wilson; Scott R Lambert
Journal:  J Cataract Refract Surg       Date:  2021-02-01       Impact factor: 3.528

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.